Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?

Blood cancer journal - 27 Jun 2014

Webersinke G, Kranewitter W, Deutschbauer S, Zach O, Hasenschwandtner S, Wiesinger K, Erdel M, Marschon R, Böhm A, Tschurtschenthaler G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Base Sequence
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Neoplasm Recurrence, Local

Share to Neoplasms, Second Primary

Share to Nuclear Proteins

Share to Nucleophosmin

Source

Open in PubMed Open full text

Identifiers

PMID: 24972150
DOI: 10.1038/bcj.2014.42
PMCID: PMC4080213

Genes

NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?PMID 24972150Read ↗

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.Semantic proximity Read ↗

Clonal evolution of NPM1 gene mutation in relapsed normal karyotype acute myeloid leukemia.Semantic proximity Read ↗

The antagonistic duality of NPM1 mutations in AML.Semantic proximity Read ↗

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaSemantic proximity Read ↗

Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability.Semantic proximity Read ↗

Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.Semantic proximity Read ↗

NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.Semantic proximity Read ↗

Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.Semantic proximity Read ↗

NPM1-mutated AML: how many diseases?Semantic proximity Read ↗

Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSemantic proximity Read ↗

NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemiaSemantic proximity Read ↗

NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.